Impact of SARS-CoV-2 Omicron on Rapid Antigen Testing Developed for Early-Pandemic SARS-CoV-2 Variants
Article
[키워드] acute respiratory syndrome
affected
Antigen
antigen test
B.1.177
BA.2
BA.5
circulating
collected
coronavirus
COVID-19
Ct-value
detection rate
Developed
diagnostic
Europe
evaluated
Evidence
false-negative
FDA
identify
Immunity
Impact
impair
increased risk
less
molecular
nasopharyngeal
North America
nucleocapsid protein
omicron
pandemic
Patient
point-of-care
positive
Postinfection
provide
Rapid
Rapid antigen tests
RAT
RATs
reduced
remained
RNA
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
significantly
spreading
Swab
Testing
Transmission
variant
Variant.
variants
Variation
[DOI] 10.1128/spectrum.02006-22 PMC 바로가기
[DOI] 10.1128/spectrum.02006-22 PMC 바로가기